Enzon Pharmaceuticals Inc (ENZN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ENZN | AMGN | CELG | GILD | BIIB |
| Company | Enzon Pharmaceuticals Inc | Amgen Inc | Celgene Corp | Gilead Sciences Inc | Biogen Inc |
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 0.0849 | 273.45 | 108.01 | 67.47 | 201.21 |
| High | 0.0880 | 274.35 | 108.59 | 67.90 | 205.36 |
| Low | 0.0849 | 267.24 | 107.27 | 65.09 | 198.11 |
| Last | 0.0880 | 269.38 | 108.24 | 65.27 | 202.46 |
| Change | +0.0100 | -3.63 | +0.11 | -1.81 | +0.47 |
| % Change | +12.82% | -1.33% | +0.10% | -2.70% | +0.23% |
| Volume | 3,991 | 1,792,068 | 191,230,496 | 15,160,858 | 1,590,136 |
| 20-Day Average Volume | 17,485 | 2,149,493 | 16,188,930 | 6,861,203 | 1,281,002 |
| Previous Close | 0.0780 | 273.01 | 108.13 | 67.08 | 201.99 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | No | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.0761 | 270.70 | 108.17 | 68.68 | 201.46 |
| 20-Day Raw Stochastic | 70.53% | 31.20% | 63.25% | 2.05% | 46.29% |
| 20-Day Relative Strength | 52.51% | 44.80% | 64.69% | 28.32% | 43.22% |
| Weighted Alpha | -67.38 | +9.12 | +46.30 | -23.73 | -34.48 |
| Today's Opinion | 56% Sell | 72% Sell | 100% Buy | 100% Sell | 88% Sell |
| Previous Opinion | 72% Sell | 40% Sell | 100% Buy | 100% Sell | 100% Sell |
| Last Month's Opinion | 88% Sell | 24% Buy | 100% Buy | 88% Sell | 100% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -7.17% since 04/10/24 | +2.52% since 04/18/24 | -1.97% since 11/13/19 | -1.35% since 04/18/24 | +6.27% since 04/18/24 |
| Low | 0.0647 on 04/15/24 | 260.68 on 04/19/24 | 107.27 on 11/20/19 | 65.09 on 04/25/24 | 189.44 on 04/19/24 |
| High | 0.0880 on 04/25/24 | 274.86 on 04/24/24 | 110.53 on 11/14/19 | 67.90 on 04/25/24 | 205.75 on 04/24/24 |
| 1-Month | |||||
| %Chg | +22.22% since 03/25/24 | -4.07% since 03/25/24 | +5.14% since 10/18/19 | -10.07% since 03/25/24 | -6.57% since 03/25/24 |
| Low | 0.0600 on 04/01/24 | 260.68 on 04/19/24 | 102.40 on 10/21/19 | 65.09 on 04/25/24 | 189.44 on 04/19/24 |
| High | 0.0997 on 04/09/24 | 288.57 on 03/28/24 | 110.70 on 11/13/19 | 73.87 on 03/28/24 | 217.57 on 03/28/24 |
| 3-Month | |||||
| %Chg | +3.53% since 01/25/24 | -13.18% since 01/25/24 | +13.63% since 08/20/19 | -18.65% since 01/25/24 | -17.77% since 01/25/24 |
| Low | 0.0600 on 04/01/24 | 260.68 on 04/19/24 | 93.41 on 08/23/19 | 65.09 on 04/25/24 | 189.44 on 04/19/24 |
| High | 0.1058 on 01/26/24 | 329.72 on 02/05/24 | 110.70 on 11/13/19 | 80.51 on 01/26/24 | 251.99 on 01/31/24 |
| 6-Month | |||||
| %Chg | -30.16% since 10/24/23 | -1.02% since 10/25/23 | +14.14% since 05/20/19 | -16.74% since 10/25/23 | -17.94% since 10/25/23 |
| Low | 0.0600 on 04/01/24 | 249.70 on 10/31/23 | 89.08 on 07/23/19 | 65.09 on 04/25/24 | 189.44 on 04/19/24 |
| High | 0.1500 on 11/10/23 | 329.72 on 02/05/24 | 110.70 on 11/13/19 | 87.86 on 01/19/24 | 268.30 on 01/03/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 5,789 | 146,436,016 | 77,035,920 | 83,519,768 | 29,361,468 |
| Shares Outstanding, K | 74,220 | 536,376 | 711,714 | 1,245,077 | 145,361 |
| Annual Sales | 0 | 28,190,000,000 | 15,281,000,000 | 27,116,000,000 | 9,835,600,000 |
| Annual Net Income | 1,370,000 | 6,717,000,000 | 4,046,000,000 | 5,665,000,000 | 1,161,100,000 |
| Last Quarter Sales | 0 | 8,196,000,000 | 4,520,000,000 | 7,114,000,000 | 2,386,300,000 |
| Last Quarter Net Income | 670,000 | 767,000,000 | 1,691,000,000 | 1,429,000,000 | 249,700,000 |
| 60-Month Beta | 0.33 | 0.58 | 1.41 | 0.19 | -0.02 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.01 on 03/20/24 | 4.71 on 02/06/24 | 2.99 on 10/31/19 | 1.72 on 02/06/24 | 3.67 on 04/24/24 |
| Latest Earnings Date | 05/03/24 | 05/02/24 | 10/31/19 | 04/25/24 | 04/24/24 |
| Most Recent Dividend | 0.240 on 09/30/19 | 2.250 on 02/15/24 | N/A | 0.770 on 03/14/24 | N/A |
| Next Ex-Dividends Date | 09/30/19 | 05/16/24 | N/A | 03/14/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 7.24 | 14.67 | 10.99 | 9.97 | 13.11 |